Key TakeawaysGLP-1 drugs might lower the risk of dangerous blood clots and death among people with autoimmune diseasesPeople taking GLP-1 drugs were 44% less likely to dieThey also had a lower risk of blood clots in their lungs or causing a stroke.WEDNESDAY, June 17, 2026 (HealthDay News) People with an autoimmune disease and obesity might lower their risk of dangerous blood clots and death by taking Ozempic or Zepbound, a new study says.Autoimmune diseases like celiac disease, vitiligo, psoriasis or rheumatoid arthritis increase the risk of severe heath emergencies because they cause inflammation and malfunctioning immune responses, researchers said.But GLP-1 medications might be able to counter that risk, researchers reported recently in the Journal of the American Heart Association.Overall, peoples risk of death was cut by nearly half if they were taking a GLP-1 drug, the study found.In this real-world analysis, we found a consistent signal toward fewer serious complications including blood clots and lower mortality among patients treated with GLP-1 receptor agonists, senior researcher Dr
Oral semaglutide and tirzepatide must overcome absorption barriers and typically require higher doses
The tirzepatide dosing guide covers its specific reconstitution and unit calculations, which differ substantially from semaglutide despite using the same type of syringe and diluent
Drug Class Analysis GLP-1 Weight Loss Drug Market by Drug Class: Injectable and Dual Agonist Therapies Command 78.4% of Revenue Drug Class Revenue Share, CAGR, and Commercial Drivers GLP-1 Obesity Drug Market 2026 Injectable GLP-1 receptor agonist monoagonists hold a 32.8% GLP-1 market revenue share in 2026 , reflecting Wegovys position as the most commercially successful weight management drug in pharmaceutical history
Key Takeaways Creatine does not directly help you lose weight or burn fat, but it supports fat loss indirectly by improving workout performance and preserving lean muscle mass during a calorie deficit
MEDVi structures treatment plans with periodic reviews to ensure safety and effectiveness
